VOLTARELIEF
Live / Allowed — Third extension granted (statement of use) (as of 30 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Jun 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98604144
- Mark type
- Word mark
- Filed
- 17 Jun 2024
- Published for opposition
- 04 Feb 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for pain relief; topical analgesics creams; analgesic balm; adhesive patches for medical purposes, namely, transdermal patches for use in the treatment of pain; adhesive patches incorporating pharmaceutical preparations, namely, transdermal patches for use in the treatment of pain
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 01 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2026 — SOU EXTENSION 3 GRANTED
- 30 Sept 2026 — SOU EXTENSION 3 FILED
- 30 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2026 — SOU EXTENSION 2 GRANTED
- 01 Apr 2026 — SOU EXTENSION 2 FILED
- 01 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2025 — SOU EXTENSION 1 GRANTED
- 30 Sept 2025 — SOU EXTENSION 1 FILED
- 30 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Feb 2025 — PUBLISHED FOR OPPOSITION